Director, Real World Value & Evidence – Hematology Oncology

Johnson & Johnson Innovative Medicine•Horsham, PA

11d•$164,000 - $282,900•Hybrid

About The Position

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com Job Function: Market Access Job Sub Function: Health Economics Outcomes Research Job Category: People Leader All Job Posting Locations: Horsham, Pennsylvania, United States of America Job Description: Director, Real World Value & Evidence (RWV&E) – Hematology Oncology About Oncology Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow. Our Oncology team is focused on the elimination of cancer by discovering new pathways and modalities to finding treatments and cures. We lead where medicine is going and need innovators with an unwavering commitment to results. Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. Learn more at https://www.jnj.com/innovative-medicine We are searching for the best talent for Director, Real World Value & Evidence (RWV&E), US Medical Affairs, Hematology, to be located in Horsham, PA. Purpose: The Director, Real World Value & Evidence (RWV&E), US Medical Affairs, Hematology-Oncology will be responsible for leading and implementing the economic modeling strategy, real-world evidence generation strategy, market access & pathway scientific strategy, and dissemination plans for J&J’s Hematology portfolio. You will be responsible for: Ensure economic modeling, real world evidence and market access scientific support requirements are understood and built-in to the US business plans with value propositions that reflect the needs of payer stakeholders, population health decision makers, pathway decision makers and lead scientific strategic planning for RWV&E activities to enable access for the hematology portfolio. Hematology portfolio RWV&E activities this role is held accountable for include but are not limited to: development and governance of economic models across the hematology portfolio and ensuring consistency and methodological alignment across multiple assets. In close collaboration with RWV&E product leads, this role supports the generation of portfolio-level and asset-specific economic models to support payer, pathway and other population health decision makers access strategy. In addition, the role leads core RWV&E activities for the hematology portfolio including identifying and prioritizing key research and analytical questions, shaping evidence generation strategy, designing and overseeing studies, conducting market access analytics, managing publications, and developing compliant communication materials (e.g. Evidence & Access decks), and partnering with MSL/RWV&E FIELD to ensure effective and compliant communication. Ensures projects and economic models are aligned to the Integrated Evidence Generation Plan (IEGP) and business needs and executed on time Collaborate with internal and external experts to develop economic models, prioritize and generate rigorous scientific data, and develop dissemination plans to support the therapeutic area's IEGP Ensures compliance with regulatory, legal and commercial regulations (for example Contract Pricing Committee, Copy Approval Committee) in conducting research and dissemination of scientific and economic modeling information Collaborate with cross-functional business partners and alliance partners on scientific strategies and economic modeling strategies to support market access for our products Directly initiate and manage economic models, research studies and other related projects Serve as subject matter, and functional area expert in responding to U.S-focused Value Assessments of our hematology products by external organizations Ensure quality of design, execution, and publication of economic models and real-world evidence studies Develop annual business plan budget, present to appropriate levels of management for approval, and manage budgeted funds appropriately Ensure quality in internal / external communications including: publications, training support of RWVE studies, and models and/or tools developed for the therapeutic area. Serve as a leader on assigned cross-functional franchise teams, with internal partners such as Scientific Affairs, Marketing, Medical Affairs, Strategic Customer Group, GCSO, Epidemiology, Government Affairs and Policy, others as needed. At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.

Requirements

A minimum of a Master's degree in Public Health, Health Services Research, Economics, Epidemiology, Pharmacy, Health Policy, or a related discipline is required; A doctorate or other advanced degree is preferred.
A minimum of 6-8 or more years or more of relevant economic modeling and real-world research experience.
Expertise in the healthcare industry, clinical knowledge or practice across multiple therapeutic areas, medical reimbursement, technical expertise in economic evaluations or patient-reported outcomes, including data analysis and statistics.
Expertise in health economic modeling techniques
Excellent in leadership skills, collaboration, influencing and communication (both written and presentation).
Serve as a leader on the assigned cross-functional franchise teams pertaining to observational data or research, market access scientific strategy, payer insights/ data needs, etc.
Experience in communicating technical data both internally and externally to non-technical audiences.
Independent high- level planning and execution of research strategies.
Solid experience in conducting Real World Evidence studies applying health economics, patient-reported outcomes, retrospective data analyses, epidemiology or health services research.
Firm understanding of drug development process including health economic inputs needed to support the value proposition.
Firm understanding of regulatory standards for approval and communication of data.
Firm understanding of United States health care systems and customers; specifically understanding unique business models and perspectives.
Firm understanding of the uses of evidence-based medicine and comparative effectiveness analyses for health policy decision-making.
Up to 30% travel required mostly national with occasional international travel.

Nice To Haves

Preferred Hematology-Oncology real-world evidence generation experience in developing and gaining management approval for value-based scientific strategies and tactics to meet both commercial and scientific objectives for a given product or therapeutic area.

Responsibilities

Ensure economic modeling, real world evidence and market access scientific support requirements are understood and built-in to the US business plans with value propositions that reflect the needs of payer stakeholders, population health decision makers, pathway decision makers and lead scientific strategic planning for RWV&E activities to enable access for the hematology portfolio.
Hematology portfolio RWV&E activities this role is held accountable for include but are not limited to: development and governance of economic models across the hematology portfolio and ensuring consistency and methodological alignment across multiple assets.
In close collaboration with RWV&E product leads, this role supports the generation of portfolio-level and asset-specific economic models to support payer, pathway and other population health decision makers access strategy.
In addition, the role leads core RWV&E activities for the hematology portfolio including identifying and prioritizing key research and analytical questions, shaping evidence generation strategy, designing and overseeing studies, conducting market access analytics, managing publications, and developing compliant communication materials (e.g. Evidence & Access decks), and partnering with MSL/RWV&E FIELD to ensure effective and compliant communication.
Ensures projects and economic models are aligned to the Integrated Evidence Generation Plan (IEGP) and business needs and executed on time
Collaborate with internal and external experts to develop economic models, prioritize and generate rigorous scientific data, and develop dissemination plans to support the therapeutic area's IEGP
Ensures compliance with regulatory, legal and commercial regulations (for example Contract Pricing Committee, Copy Approval Committee) in conducting research and dissemination of scientific and economic modeling information
Collaborate with cross-functional business partners and alliance partners on scientific strategies and economic modeling strategies to support market access for our products
Directly initiate and manage economic models, research studies and other related projects
Serve as subject matter, and functional area expert in responding to U.S-focused Value Assessments of our hematology products by external organizations
Ensure quality of design, execution, and publication of economic models and real-world evidence studies
Develop annual business plan budget, present to appropriate levels of management for approval, and manage budgeted funds appropriately
Ensure quality in internal / external communications including: publications, training support of RWVE studies, and models and/or tools developed for the therapeutic area.
Serve as a leader on assigned cross-functional franchise teams, with internal partners such as Scientific Affairs, Marketing, Medical Affairs, Strategic Customer Group, GCSO, Epidemiology, Government Affairs and Policy, others as needed.

Benefits

employees are eligible to participate in the Company’s consolidated retirement plan (pension) and savings plan (401(k)).
This position is eligible to participate in the Company’s long-term incentive program.
Vacation –120 hours per calendar year
Sick time - 40 hours per calendar year; for employees who reside in the State of Colorado –48 hours per calendar year; for employees who reside in the State of Washington –56 hours per calendar year
Holiday pay, including Floating Holidays –13 days per calendar year
Work, Personal and Family Time - up to 40 hours per calendar year
Parental Leave – 480 hours within one year of the birth/adoption/foster care of a child
Bereavement Leave – 240 hours for an immediate family member: 40 hours for an extended family member per calendar year
Caregiver Leave – 80 hours in a 52-week rolling period
Volunteer Leave – 32 hours per calendar year
Military Spouse Time-Off – 80 hours per calendar year